I specialize in economic evaluation and priority setting research in health-related interventions. I am currently working on the country translation phase of Disease Control Priorities (DCP), which involves adapting global evidence in order to design new health benefit packages in Pakistan and other settings in sub-Saharan Africa.  

My methodological focus is on cost-effectiveness analyses alongside randomized controlled trials in low- and middle-income countries and I have expertise in the areas of HIV and GBV. Recent trials I have worked on include: Cotrimoxazole Preventive Therapy discontinuation among HIV-positive adults in Uganda, GBV prevention strategies in Ghana and Rwanda, and enhanced demand creation to increase uptake of Voluntary Medical Male Circumcision in Tanzania.

I have experience in cost data collection and analysis, having worked in the areas syphilis testing (Tanzania, Zambia and Peru) and HIV point-of-care diagnostics (Tanzania and Zambia).

I have also conducted qualitative work in the areas of antiretroviral distribution (Botswana), antimalarial distribution (Madagascar), vaccine introductions (Rwanda, Ethiopia and Cameroon), substance abuse in high-risk populations (UK), and introduction of HIV diagnostic technologies (Tanzania and Zambia).